Whole-body Synthesis-secretion Rates of Long-chain N-3 PUFAs from Circulating Unesterified Alpha-linolenic Acid in Unanesthetized Rats

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2008 Dec 17

PMID 19074373

Citations 25

Authors

Fei Gao

Dale Kiesewetter

Lisa Chang

Kaizong Ma

Jane M Bell

Stanley I Rapoport

Miki Igarashi

Affiliations

Soon will be listed here.

Abstract

Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), long-chain n-3 PUFAs important for brain and heart function, can be obtained from dietary fish products or by liver synthesis from alpha-linolenic acid (alpha-LNA). Their daily human dietary requirements are not clear, and their liver synthesis rates in humans and nonhumans are unknown. We estimated whole-body (presumably liver) synthesis rates in unanesthetized rats by infusing [U-(13)C]alpha-LNA intravenously for 2 h and measuring labeled and unlabeled n-3 PUFA in arterial plasma using negative chemical ionization GC-MS. Newly synthesized esterified [(13)C]DHA, [(13)C]EPA, and [(13)C]docosapentaenoic acid (DPA) appeared in arterial plasma after 60 min of infusion, then their concentrations rose in an S-shaped manner. Esterified concentration x plasma volume data were fit with a sigmoidal equation, whose peak first derivatives provided synthesis rates of unlabeled EPA, DPA, and DHA equal to 8.40, 6.27, and 9.84 mumol/day, respectively. The DHA synthesis rate exceeded the published daily rat brain DHA consumption rate by 30-fold, suggesting that liver synthesis from alpha-LNA could maintain brain DHA homeostasis were DHA absent from the diet. This stable isotope infusion method could be used to quantify whole-body DHA synthesis rates in human subjects.

Citing Articles

Investigation of Lysophospholipids-DHA transport across an human model of blood brain barrier.

Hachem M, Ali A, Yildiz I, Landry C, Gosselet F Heliyon. 2024; 10(19):e38871.

PMID: 39421371 PMC: 11483317. DOI: 10.1016/j.heliyon.2024.e38871.

Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study.

Yonezawa T, Marasigan C, Matsumiya Y, Maeda S, Motegi T, Momoi Y Open Vet J. 2023; 13(7):942-947.

PMID: 37614731 PMC: 10443822. DOI: 10.5455/OVJ.2023.v13.i7.14.

Unique Biomarker Characteristics in Gestational Diabetes Mellitus Identified by LC-MS-Based Metabolic Profiling.

Meng X, Zhu B, Liu Y, Fang L, Yin B, Sun Y J Diabetes Res. 2021; 2021:6689414.

PMID: 34212051 PMC: 8211500. DOI: 10.1155/2021/6689414.

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease.

Martins M, Silva R, Pinto M, Sousa E Pharmaceuticals (Basel). 2020; 13(9).

PMID: 32933034 PMC: 7558913. DOI: 10.3390/ph13090242.

The profile of polyunsaturated fatty acids in juvenile idiopathic arthritis and association with disease activity.

Gorczyca D, Postepski J, Czajkowska A, Pasciak M, Prescha A, Olesinska E Clin Rheumatol. 2017; 36(6):1269-1279.

PMID: 28247163 PMC: 5486496. DOI: 10.1007/s10067-017-3586-9.

References

Kris-Etherton P, Hill A . N-3 fatty acids: food or supplements?. J Am Diet Assoc. 2008; 108(7):1125-30. DOI: 10.1016/j.jada.2008.04.025. View

Igarashi M, DeMar Jr J, Ma K, Chang L, Bell J, Rapoport S . Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res. 2006; 48(1):152-64. DOI: 10.1194/jlr.M600396-JLR200. View

Rosell M, Lloyd-Wright Z, Appleby P, Sanders T, Allen N, Key T . Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr. 2005; 82(2):327-34. DOI: 10.1093/ajcn.82.2.327. View

Anderson G, Connor W . Uptake of fatty acids by the developing rat brain. Lipids. 1988; 23(4):286-90. DOI: 10.1007/BF02537334. View

Igarashi M, Ma K, Chang L, Bell J, Rapoport S . Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain. J Lipid Res. 2007; 48(11):2463-70. DOI: 10.1194/jlr.M700315-JLR200. View

Kris-Etherton P, Harris W, Appel L . Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002; 106(21):2747-57. DOI: 10.1161/01.cir.0000038493.65177.94. View

Umhau J, Zhou W, Carson R, Rapoport S, Polozova A, DeMar J . Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res. 2008; 50(7):1259-68. PMC: 2694326. DOI: 10.1194/jlr.M800530-JLR200. View

Burdge G, Calder P . Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005; 45(5):581-97. DOI: 10.1051/rnd:2005047. View

Rapoport S, Chang M, Spector A . Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res. 2001; 42(5):678-85. View

10.

Liang X, Wu L, Hand T, Andreasson K . Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem. 2005; 92(3):477-86. DOI: 10.1111/j.1471-4159.2004.02870.x. View

11.

Gibbons G . Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J. 1990; 268(1):1-13. PMC: 1131384. DOI: 10.1042/bj2680001. View

12.

Burdge G, Jones A, Wootton S . Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*. Br J Nutr. 2002; 88(4):355-63. DOI: 10.1079/BJN2002662. View

13.

Igarashi M, Ma K, Chang L, Bell J, Rapoport S . Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2. J Lipid Res. 2008; 49(8):1735-45. PMC: 6075821. DOI: 10.1194/jlr.M800093-JLR200. View

14.

Vermunt S, Mensink R, Simonis M, Hornstra G . Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid. Lipids. 2000; 35(2):137-42. DOI: 10.1007/BF02664762. View

15.

Salem Jr N, Litman B, Kim H, Gawrisch K . Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001; 36(9):945-59. DOI: 10.1007/s11745-001-0805-6. View

16.

Simopoulos A . Human requirement for N-3 polyunsaturated fatty acids. Poult Sci. 2000; 79(7):961-70. DOI: 10.1093/ps/79.7.961. View

17.

DeMar Jr J, Ma K, Bell J, Rapoport S . Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem. 2004; 91(5):1125-37. DOI: 10.1111/j.1471-4159.2004.02789.x. View

18.

Washizaki K, Smith Q, Rapoport S, Purdon A . Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J Neurochem. 1994; 63(2):727-36. DOI: 10.1046/j.1471-4159.1994.63020727.x. View

19.

Cunnane S, Menard C, Likhodii S, Brenna J, Crawford M . Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and alpha-linolenate. Prostaglandins Leukot Essent Fatty Acids. 1999; 60(5-6):387-92. DOI: 10.1016/s0952-3278(99)80018-0. View

20.

Lefkowitz W, Lim S, Lin Y, Salem Jr N . Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat. Pediatr Res. 2004; 57(1):157-65. DOI: 10.1203/01.PDR.0000147572.57627.AE. View